Nuedexta for Neurobehavioral Symptoms of Adults With Autism Spectrum Disorder

Trial Profile

Nuedexta for Neurobehavioral Symptoms of Adults With Autism Spectrum Disorder

Completed
Phase of Trial: Phase II

Latest Information Update: 11 Dec 2017

At a glance

  • Drugs Dextromethorphan/quinidine (Primary)
  • Indications Autistic disorder
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Nov 2017 Status changed from active, no longer recruiting to completed.
    • 28 Apr 2017 Results (n=13) presented at the 69th Annual Meeting of the American Academy of Neurology.
    • 31 Jul 2013 Planned End Date changed from 1 Jun 2013 to 1 Aug 2014 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top